[{"indications": "Indications\u00a0HIV infection in combination with other antiretroviral drugs when\r\nno suitable alternative available and when prescribed for shortest\r\nperiod possible", "name": "STAVUDINE ", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "5 Infections", "5.3 Antiviral drugs", "5.3.1 HIV infection", "Nucleoside reverse transcriptase inhibitors", "STAVUDINE"], "cautions": "Cautions\u00a0\n(From Nucleoside reverse transcriptase inhibitors: British National Formulary)\nNucleoside reverse transcriptase inhibitors; also history of peripheral neuropathy, excessive\r\nalcohol intake, concomitant use of isoniazid\u2014risk\r\nof peripheral neuropathy (see under Side-effects); history of pancreatitis or concomitant\r\nuse with other drugs associated with pancreatitis; interactions: Appendix 1 (stavudine)", "side-effects": "Side-effects\u00a0see notes above; also peripheral neuropathy (switch to another antiretroviral if peripheral neuropathy develops), abnormal dreams, cognitive dysfunction, drowsiness, depression,\r\npruritus; less commonly anxiety, gynaecomastia", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/57191.htm", "doses": ["adult under 60\u00a0kg, 30\u00a0mg\r\nevery 12 hours preferably at least 1 hour before food; 60\u00a0kg and over,\r\n40\u00a0mg every 12 hours; child 1 month\u201318\r\nyears see BNF for Children"], "pregnancy": "Pregnancy\u00a0manufacturer advises use only if potential benefit\r\noutweighs risk"}]